The Iliac/SFA/Popliteal Center

Filter Your Results




Trial Subanalysis Finds Empagliflozin Can Reduce Risk of Cardiovascular Death in Patients With Type 2 Diabetes and PAD

November 21, 2017 -- Data from the EMPA-REG OUTCOME trial showed that empagliflozin reduced the risk of cardiovascular death compared with placebo when added to standard of ca…

Network Meta-Analysis Evaluates Endovascular Interventions for Femoropopliteal Disease

November 8, 2017 -- Findings from a study using network meta-analysis (NMA) to determine the optimal endovascular strategy for managing femoropopliteal peripheral artery disea…

SHIELD Trial Results Announced for Symic Bio's SB-030 in Peripheral Vascular Disease

November 1, 2017 -- Symic Bio announced results from the phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral vascular dis…

TRANSCEND Pivotal Clinical Trial Commences for Surmodics' SurVeil DCB

November 2, 2017 -- Surmodics, Inc. announced enrollment of the first patient in TRANSCEND, the pivotal clinical trial for the company's SurVeil drug-coated balloon (DCB).…

Data Published for Medtronic's In.Pact Admiral DCB in De Novo In-Stent Restenosis

October 18, 2017 -- Findings from the IN.PACT Global study's de novo in-stent restenosis (ISR) imaging cohort were published by Marianne Brodmann, MD, et al in Journal of …

MAJESTIC 3-Year Data Published for Boston Scientific's Eluvia DES

October 11, 2017 -- The 3-year results of the MAJESTIC first-in-human study of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) for treating femoropopli…

TINTIN Trial to Evaluate Combined Therapy With iVascular's Luminor DCB and iVolution BMS

September 29, 2017 -- iVascular, based in Barcelona, Spain, recently announced the initiation of the TINTIN trial, which is evaluating the combined therapy of the company…

Study Presented at CIRSE Explores Ocular Radiation Exposure and Role of Protective Eyewear

September 22, 2017 -- Gerard Goh, MBBS, FRANZCR, EBIR, and colleagues presented data at CIRSE 2017, the annual congress of the Cardiovascular and Interventional Radiological S…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.